Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BRADENTON, Fla., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Dr. Kristin Kemper, experienced chiropractor, has recently joined the chiropractic team, reports Lakewood Ranch Chiropractic. Doctors and staff...
-
FAIRFAX, Va., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Patients continue to receive excellence in chiropractic care from a range of evolving and specialized chiropractic techniques and ongoing research...
-
CARY, N.C., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Cary veterinarian Chatham Animal Hospital is pleased to announce they will be sponsoring the third annual Wiener Dog Race at the Triangle...
-
CAMBRIDGE, Mass., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc., a company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today...
-
ANN ARBOR, Mich., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Phrixus Pharmaceuticals is announcing that FDA allowed Phrixus’s IND for Carmeseal-MD (P-188 NF) in Duchenne muscular dystrophy (DMD). The...
-
SOUTH SAN FRANCISCO, Calif., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the discovering and developing novel...
-
Sarasota, FL, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “CSF Management Market (CSF Drainage Systems and CSF Shunts) for Hospitals, Outpatient Facilities,...
-
SALT LAKE CITY, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Myriad RBM, Inc., a wholly owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN) a global leader in personalized medicine, announced today that...
-
Unite Cellular Immunotherapy Expertise to Accelerate Clinical Translation of Off-the-Shelf Products Offering Broad Patient Access Collaboration to Use Engineered Pluripotent Cell Lines to...
-
RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced positive results from a proof-of-concept study of its broad spectrum...